Randomized prospective comparison between erythropoietin and androgens in CAPD patients

Kidney International

Volumn 61, Issue 4, 2002, Pages 1537-1544

  Navarro, Juan F ^a   Mora, Carmen ^a   Macía, Manuel ^a   García, Javier ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

Androgens; Anemia; Erythropoietin; Malnutrition; Peritoneal dialysis; Renal replacement therapy

Indexed keywords

ALBUMIN; ANABOLIC AGENT; CREATININE; HEMOGLOBIN; NANDROLONE DECANOATE; PREALBUMIN; PROTEIN; RECOMBINANT ERYTHROPOIETIN; SOMATOMEDIN C; TRANSFERRIN; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ANTHROPOMETRIC PARAMETERS; ARM MUSCLE; ARTICLE; BLOOD CHEMISTRY; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SKINFOLD; TREATMENT OUTCOME; TRICEPS BRACHII MUSCLE; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

EID: 0036227448     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00271.x     Document Type: Article

References (56)

1. USRDS 1998 annual data report
2. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study
3. Nutritional status of patients undergoing continuous ambulatory peritoneal dialysis (CAPD)
4. Nutritional assessment of continuous ambulatory peritoneal dialysis patients
5. Nutritional status of patients on hemodialysis and peritoneal dialysis
6. Nutritional requeriments of peritoneal dialysis
7. Cross-sectional comparison of malnutrition in contiuous ambulatory peritoneal dialysis and hemodialysis patients
8. Nutritional effects and nutritional management of chronic peritoneal dialysis
9. The CANADA-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous ambulatory peritoneal dialysis: Association with clinical outcomes
10. Nutritional status of CAPD patients at three years
11. Malnutrition as the main factor in morbidity and mortality of dialysis patients
12. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis
13. Effect of malnutrition on morbidity and mortality in maintenance dialysis patients
14. Nutrition in end-stage renal disease
15. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients
16. Predictors of survival in continuous ambulatory peritoneal dialysis patients: The importance of prealbumin and other nutritional and metabolic markers
17. Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study
18. Influence of nutritional status on continuous ambulatory peritoneal dialysis patient survival
19. Is malnutrition a problem for the patient on peritoneal dialysis? Nutritional markers as predictors of survival in patients on CAPD
20. Erythropoietin-induced changes in protein nutrition: Quantitative assessment by urea kinetic modeling analysis
21. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin
22. Effect of erythropoietin treatment on nutritional status of continuous ambulatory peritoneal dialysis patients
23. Effect of the correction of anemia with recombinant human erythropoietin on growth of children treated with CAPD
24. Effect of recombinant human erythropoietin on nutritional status and plasma lipids in uremic patients
25. Factors contributing to catabolism in end-stage renal disease patients
26. Erythropoietic response of dialyzed patients to testosterone administration
27. Testosterone therapy for anemia in maintenance dialysis
28. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis
29. Androgen versus erythropoietin for the treatment of anemia in hemodlialyzed patients. A prospective study
30. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis
31. Androgens for the treatment of anemia in peritoneal dialysis patients
32. Total body water volumes for adult males and females estimated from simple anthropometric measurements
33. Update on peritoneal dialysis worldwide
34. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used?
35. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease
36. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients
37. Androgen therapy for anaemia of chronic renal failure
38. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: A prospective study
39. Effect of steroids on the cycling of haematopoietic stem cells
40. Stimulatory effects of androgens on normal children's bone marrow in culture: Effects on BFU-E, CFU-E, and uroporphyrinogen I synthase activity
41. Insilin-like growth factor I stimulates human erythroid colony formation in vitro
42. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells
43. Insulin-like growth factor I: A modulator of erythropoiesis in uraemic patients?
44. Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis
45. Anabolic steroids in the treatment of malnourished CAPD patients: A retrospective study
46. Anabolic effects of nandrolone decanoate in patients receiving dialysis
47. Is there a role for androgenic anabolic steroids in medical practice?
48. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor (IGF-1) in humans
49. Testosterone increases serum 1,25-dihydroxyvitamin D and insulin-like growth factor-I in hypogonadal men
50. Testosterone administration increases insulin-like growth factor-I levels in normal men
51. Nandrolone decanoate does not enhance training effects but increases IGF-I mRNA in rat diaphragm
52. Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure
53. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients
54. Anabolic agents in kidney disease: The effect of formebolone on protein synthesis in patients with renal insufficiency or nephrosis
55. Identification and characterization of the human hepatic androgen receptor
56. Androgen receptor in human liver: Characterization and quantification in normal and diseased liver